Zhongshan Hospital of Fudan University has proposed for the first time to adopt the AI system "RL-DITR" based on reinforcement learning algorithm to formulate insulin decision-making strategy, which can effectively improve the accuracy of insulin treatment plan for type 2 diabetes mellitus patients, and provide dynamic diagnostic and treatment plan for type 2 diabetes mellitus patients.
Chinese expert publishes research results: using AI to provide dynamic diagnosis and treatment programs for diabetes patients
Previous: 华大智造aLab实验室落地香港科学园
Next: 快手AIGC玩评功能进行内测